NCT03572556View on ClinicalTrials.gov

Prospective Descriptive Study of the Angiogenic T Cell Population in Subjects With Hereditary Hemorrhagic Telangiectasia (HHT)

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

June 28, 2018

Primary Completion Date

March 9, 2020

Study Completion Date

May 3, 2020

Conditions
Hereditary Hemorrhagic Telangiectasia
Interventions
BIOLOGICAL

Blood samples

"* 5 mL dry tube to separate serum~* Two 6 mL EDTA tubes for plasma separation~* Eight 6 mL heparinized tubes for flow cytometry (quantification of TANG such as CD3+CD31+CXCR4+ and CEC) and quantification of angiogenesis markers."

OTHER

Epistaxis charts

Three monthly epistaxis charts to be completed

Trial Locations (1)

21079

CHU Dijon Bourgogne, Dijon

All Listed Sponsors
lead

Centre Hospitalier Universitaire Dijon

OTHER

NCT03572556 - Prospective Descriptive Study of the Angiogenic T Cell Population in Subjects With Hereditary Hemorrhagic Telangiectasia (HHT) | Biotech Hunter | Biotech Hunter